The full name of Repetinib is Repetinib Tablets, and the therapeutic effect of gastrointestinal mesenchymal tumor using Repetinib Tablets is still good. Repitinib is suitable for the treatment of adult patients with advanced gastrointestinal mesenchymal stromal tumor (GIST) who have previously received three or more tyrosine kinase inhibitors (including imatinib), in the treatment of advanced gastrointestinal mesenchymal stromal tumors, Repitinib tablets still achieved good results, which is related to the mechanism of action of this type of drug. It can directly target the switching pocket of the kinase and bind to it, and it also interacts with the activation loop, which can play the role of stabilizing the activation loop, and after activating the KIT kinase and stabilizing it, it will block the signaling and successfully inhibit the proliferation of tumor cells. Long-term use of this type of drug may occur hair loss, fatigue, nausea, abdominal pain and constipation, you need to regulate the use of medication under the guidance of a doctor to avoid the risk.